Showing results (1301-1310 of 2,286) with videos related to
Sort By:
Pageof 229
HIV Medicine|July 14, 2005
Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapyS F Stone, P Price, M A FrenchHIV Medicine|January 27, 2005
Indinavir/ritonavir-based therapy in HIV-1-infected antiretroviral therapy-naive patients: comparison of 800/100 mg and 400/100 mg twice dailyD Konopnicki, S De Wit, B Poll, et al.HIV Medicine|January 27, 2005
Advantages of flow cytometry immunophenotyping for the diagnosis of central nervous system non-Hodgkin's lymphoma in AIDS patientsD Subirá, M Górgolas, S Castañón, et al.HIV Medicine|January 27, 2005
Successful administration of aggressive chemotherapy concomitant to tuberculostatic and highly active antiretroviral therapy in a patient with AIDS-related Burkitt's lymphomaC Lehmann, C Wyen, C Hoffmann, et al.HIV Medicine|May 14, 2004
Castleman's disease and HIV infection in AustraliaS Loi, D Goldstein, K Clezy, et al.HIV Medicine|May 14, 2004
Isolated antibodies against the core antigen of hepatitis B virus in HIV-infected patientsD Neau, M Winnock, T Galpérine, et al.HIV Medicine|May 14, 2004
HIV and hepatitis C coinfection within the CAESAR studyJ Amin, M Kaye, S Skidmore, et al.HIV Medicine|April 6, 2005
Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003H B Krentz, G Kliewer, M J GillHIV Medicine|April 6, 2005
The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapyP Cardiello, P Srasuebkul, E Hassink, et al.HIV Medicine|September 15, 2005
Fatigue among HIV-infected patients in the era of highly active antiretroviral therapyM Henderson, F Safa, P Easterbrook, et al.Pageof 229